Smoking exposure on diagnosis and survival of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from REHAP registry.
Abstract
Cigarette smoking is associated with delayed diagnosis and worse survival outcomes in PAH but not in CTEPH. Male ever-smokers patients with PAH has worse prognosis than female ever-smokers. Further research is warranted to elucidate the underlying mechanisms contributing to the negative correlation between smoking and PAH.
What are the key findings of this study?
Smoking affects how quickly people find out they have pulmonary arterial hypertension (PAH) and can make it harder for them to live long. Men who smoke tend to have worse outcomes than women who smoke in this condition. It鈥檚 important to learn more about how smoking links to these health issues, so we can help people better. 馃毉
Key Points
Objective
The study aims to investigate the effects of smoking on the diagnosis and survival of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).
Methods
- Utilized data from the REHAP registry
- Analyzed outcomes based on smoking status
- Compared survival rates between genders among ever-smokers